Intl. Biotechnology Trust PLC Portfolio Update (5561L)
20 July 2017 - 2:04AM
UK Regulatory
TIDMIBT
RNS Number : 5561L
Intl. Biotechnology Trust PLC
19 July 2017
INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)
Portfolio Update as at 30 June 2017
Net Assets GBP240m
Net Assets per share 638p
Share price 601p
Total value of unquoted GBP22m
investments
Total number of portfolio
companies 91
Dividend 4% of NAV
per annum
Top Ten Quoted Investments
Company Name % NAV
Regeneron 7.6
Celgene 7.4
Vertex 5.6
Biogen 5.3
Genmab 5.3
Alexion 3.8
Biomarin 3.5
Incyte 3.1
Amgen 2.8
Gilead 2.8
-----------
Total 47.2
Geographical Allocation % NAV
US & Canada 83
Europe & UK 17
-----------
Total 100
Quoted/Unquoted Allocation % NAV
Quoted 91
Unquoted 9
-----------
Total 100
NAV % Market Cap % NAV
Large Cap >USD10BN 53
Mid Cap =USD1-10BN 24
Small Cap <USD1BN 23
-----------
Total 100
NAV % by Therapeutic Areas % NAV
Oncology 35
Orphan 14
Ophthalmology 10
CNS 8
Inflammation 7
Medtech 2
Other 24
-----------
Total 100
BNP Paribas Secretarial Services Limited
Company Secretary
19 JULY 2017
This information is provided by RNS
The company news service from the London Stock Exchange
END
PFUBLGDRXGBBGRC
(END) Dow Jones Newswires
July 19, 2017 12:04 ET (16:04 GMT)
International Biotechnol... (LSE:IBT)
Historical Stock Chart
From Apr 2024 to May 2024
International Biotechnol... (LSE:IBT)
Historical Stock Chart
From May 2023 to May 2024